We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients Product Name:Fever Formula softgel CAS No.:- Standard:In-house Standards Price(USD):0.00 Company:Shineway Pharmaceutical Group Ltd.
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Ingredients:
Isatis root, Baicalin, Japanese Honeysuckle flower, Cape Jasmine fruit, etc.
Claim:
Fever caused by upper respiratory infection (URI) or viral influenza, acute suppurative tonsillitis, acute pharyngitis, acute tracheitis
Applicable to:
People who have the symptoms of swollen sore throat, yellow tongue, fidget, high persistent fever caused by viral influenza.
Drection:
1-2capsules each time, 3 times daily
Warning:
1. For weak, sweating or diarrheal patient, this product should be used with caution. 2. The pregnant, hypertension or heart disease patients should take this medicine with caution. 3. During the meditation, cigarettes, wine, spicy or greasy food is prohibited. 4. People who have disease of liver, kidney, diabetes or other severe chronic disease should take under the doctor’s instruction. 5. Those who are allergic to this product or have history of drug allergy should not use this product. People of allergic constitution should not use this product.
Eight years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
